Amour Venter

University of Oradea — Romania

Medicine · Health Sciences

32h-index5.0kcitations63works0.22yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Tuberculosis Research and Epidemiology(47), Mycobacterium research and diagnosis(27), Pneumonia and Respiratory Infections(16), Antibiotic Resistance in Bacteria(9), Cancer therapeutics and mechanisms(9)

Publications61 total

The Impact of Metabolic Comorbidities (Diabetes, Hypertension) on the Severity and Progression of Oropharyngeal Infections
In Vivo·2026Open Access
The role of dental status in the pathogenesis and severity of peritonsillar and cervical infections
Frontiers in Medicine·2025Open Access
Child admitted with a scrotal haematoma, discharged with coarctation of the aorta
BMJ Case Reports·2025
Correlation Between Vitamin D Deficiency (25(OH)D3) and the Severity of Purulent Oropharyngeal Infections
Journal of Clinical Medicine·2025· 1 citedOpen Access
Glycal Forte® (calcium-stabilized glycerol), a novel feed ingredient, promotes rumen function in dairy cows
Journal of Applied Animal Nutrition·2024Open Access
Liquid mycobacterial culture outcomes after different sputum collection techniques before and during treatment
Tuberculosis·2019· 3 cited
Protein binding of rifampicin is not saturated when using high-dose rifampicin
Journal of Antimicrobial Chemotherapy·2018· 19 cited
Erratum for Alsultan et al., “Population Pharmacokinetics of AZD-5847 in Adults with Pulmonary Tuberculosis”
Antimicrobial Agents and Chemotherapy·2017Open Access
Population Pharmacokinetics of AZD-5847 in Adults with Pulmonary Tuberculosis
Antimicrobial Agents and Chemotherapy·2017· 8 citedOpen Access
Time Trends in Sputum Mycobacterial Load and Two-Day Bactericidal Activity of Isoniazid-Containing Antituberculosis Therapies
Antimicrobial Agents and Chemotherapy·2017· 10 citedOpen Access
High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial
The Lancet Infectious Diseases·2016· 380 citedOpen Access
A Multilaboratory, Multicountry Study To Determine MIC Quality Control Ranges for Phenotypic Drug Susceptibility Testing of Selected First-Line Antituberculosis Drugs, Second-Line Injectables, Fluoroquinolones, Clofazimine, and Linezolid
Journal of Clinical Microbiology·2016· 48 citedOpen Access
A Multilaboratory, Multicountry Study To Determine Bedaquiline MIC Quality Control Ranges for Phenotypic Drug Susceptibility Testing
Journal of Clinical Microbiology·2016· 43 citedOpen Access
Early Bactericidal Activity of AZD5847 in Patients with Pulmonary Tuberculosis
Antimicrobial Agents and Chemotherapy·2016· 26 citedOpen Access
MIC of Delamanid (OPC-67683) against Mycobacterium tuberculosis Clinical Isolates and a Proposed Critical Concentration
Antimicrobial Agents and Chemotherapy·2016· 55 citedOpen Access
Direct Susceptibility Testing of Mycobacterium tuberculosis for Pyrazinamide by Use of the Bactec MGIT 960 System
Journal of Clinical Microbiology·2016· 28 citedOpen Access
A Step toward an Optimized Rifampin Dose Completed
American Journal of Respiratory and Critical Care Medicine·2015· 7 cited
Efficiency and safety of the combination of moxifloxacin, pretomanid (PA-824), and pyrazinamide during the first 8 weeks of antituberculosis treatment: a phase 2b, open-label, partly randomised trial in patients with drug-susceptible or drug-resistant pulmonary tuberculosis
The Lancet·2015· 248 cited
A Dose-Ranging Trial to Optimize the Dose of Rifampin in the Treatment of Tuberculosis
American Journal of Respiratory and Critical Care Medicine·2015· 311 citedOpen Access
Early phase evaluation of SQ109 alone and in combination with rifampicin in pulmonary TB patients
Journal of Antimicrobial Chemotherapy·2015· 91 citedOpen Access
page 1 of 4Next →

Frequent Co-authors

Andreas H. Diacon(28), Peter R. Donald(20), Rodney Dawson(18), Martin J. Boeree(9), Kim Narunsky(9), Norbert Heinrich(8), Stephen H. Gillespie(8), Michael Höelscher(8), Patrick Phillips(7), Jeannine du Bois(7), Paul D. van Helden(7), J. S. Maritz(7), Sven O. Friedrich(7), Florian von Groote-Bidlingmaier(6), Rob E. Aarnoutse(6), Christo van Niekerk(5), Sunita Rehal(5), Georgette Plemper van Balen(5), D. P. Parkin(5), F A Sirgel(5)